February 8, 2025 06:00 AM EST

Q4 earnings updates; Biogen details revised research strategy; RFK Jr. advances out of Senate committee; and more

Nicole DeFeudis

Editor

Welcome back to Endpoints Weekly! Our team tracked fourth-quarter earnings reports from about a dozen companies this week. We’ll walk you through the highlights, including …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Q4 earnings updates; Biogen details revised research strategy; RFK Jr. advances out of Senate committee; and more

Nicole DeFeudis

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Updated: Bay Area biotech VC to shut down 15 months after launch, sources say, after key investor pulls out

Major FDA staff cuts would slow drug reviews, experts say

Bristol Myers prunes pipeline amid new round of cost cuts

Trump 2.0 blog: Thousands of federal health workers could get axed, according to reports

Senators ask FDA to dig into 'misleading' Super Bowl ad from Hims

Updated: Lilly posts 45% sales jump, culls four programs across obesity, Alzheimer's, heart failure and eczema

Q4 earn­ings up­dates; Bio­gen de­tails re­vised re­search strat­e­gy; RFK Jr. ad­vances out of Sen­ate com­mit­tee; and more

Editor

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

Q4 earnings updates; Biogen details revised research strategy; RFK Jr. advances out of Senate committee; and more